From “Undetectable” to “Sensitive Detection”: Advances in Derivatization Techniques for LC-MS Analysis of Genotoxic Impurities
Abstract
1. Introduction
2. Fundamental Principles and Strategic Framework of Derivatization in GTI Analysis
2.1. Chemical Basis of Derivatization: From Functional Group Reactivity to MS Detectability
2.2. Critical Analytical Performance Metrics and Regulatory Alignment
2.2.1. Conversion Yield and Its Regulatory Significance
2.2.2. Reproducibility, Robustness and ICH Q2(R2) Expectations
2.2.3. Byproduct Interference and Ion Suppression—Avoiding False Results
2.2.4. Derivative Stability
2.2.5. Matrix Effects on Derivatization Efficiency
2.2.6. The Role of Isotopically Labeled Internal Standards in Regulatory Compliance
2.3. Trade-Offs in Derivatization Method Development
3. Derivatization Reagents: Design and Case Studies
3.1. Cross-Comparison of Derivatization Reagents by Functional Group
3.2. From Reaction Tags to MS/MS Information Carriers: The DMAP-to-BPPC Evolution
4. Derivatization Strategies for Different Functional Groups: Practical Challenges and Solutions
4.1. Alkyl Halides
4.2. Nitroaromatics
4.3. Sulfonyl Chlorides
4.4. Hydroxylamine
4.5. Alcohols and Hydrazines
4.6. Epoxides
4.7. Aldehydes, Ketones, Carboxylic Acids, and Amines
5. Comparison of Pre-Column and Post-Column Derivatization Modes
5.1. Pre-Column Derivatization
5.2. Post-Column Derivatization
5.3. Emerging On-Line Strategies: Gas-Phase and Automated Pre-Column Approaches
5.3.1. Gas-Phase Derivatization via Ion–Molecule Reactions
5.3.2. Automated Pre-Column Derivatization Using Modern Autosamplers
5.3.3. Photochemical Derivatization: A Note of Caution
5.4. Systematic Comparison of Pre-Column and Post-Column Derivatization
6. Conclusions and Perspectives
6.1. Core Consensus: Derivatization as the Most Effective Strategy for “Invisible” GTIs
6.2. Current Bottlenecks
6.3. Future Directions
6.3.1. High-Throughput Derivatization
6.3.2. Smart Reagent Design
6.3.3. Online SPE-Derivatization-LC-MS Integration
6.3.4. Green Derivatization
6.3.5. Systematic Evaluation of Matrix Tolerance
6.4. Concluding Remarks
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| API | active pharmaceutical ingredient |
| APCI | atmospheric pressure chemical ionization |
| BPPC | butyl 1-(pyridin-4-yl)piperidine-4-carboxylate |
| CE | capillary electrophoresis |
| CID | collision-induced dissociation |
| DDRIs | DNA direct reactive impurities |
| DMAP | 4-dimethylaminopyridine |
| DNPH | 2,4-dinitrophenylhydrazine |
| DIA | data-independent acquisition |
| ESI | electrospray ionization |
| FMOC-Cl | 9-fluorenylmethyl chloroformate |
| FT-ICR | Fourier transform ion cyclotron resonance |
| GC-ECNI-MS | gas chromatography-electron capture negative ionization-mass spectrometry |
| GTI | genotoxic impurity |
| HILIC | hydrophilic interaction liquid chromatography |
| HRMS | high-resolution mass spectrometry |
| ICP-MS | inductively coupled plasma mass spectrometry |
| IL-IS | isotopically labeled internal standard |
| LC-MS | liquid chromatography-mass spectrometry |
| LC-MS/MS | liquid chromatography-tandem mass spectrometry |
| LOD | limit of detection |
| LOQ | limit of quantification |
| MRM | multiple reaction monitoring |
| NMR | nuclear Magnetic Resonance |
| NLS | neutral loss scanning |
| 3-NPH | 3-nitrophenylhydrazine |
| PCD | post-column derivatization |
| PFBCl | pentafluorobenzoyl chloride |
| PFBHA | pentafluorobenzylhydroxylamine |
| QuEChERS | Quick, Easy, Cheap, Effective, Rugged, and Safe |
| RSD | relative standard deviation |
| SIR | selected ion recording |
| SN2 | bimolecular nucleophilic substitution |
| SPE | solid-phase extraction |
| SPME | solid-phase microextraction |
| TEA | triethylamine |
| UPLC | ultra-performance liquid chromatography |
References
- Ramegowda, K.K.; Mishra, S.; Prakash, V.M. Regulatory Pathway for Genotoxic Impurities in Europe, US, Canada, India, Australia and UK. Indian J. Pharm. Educ. Res. 2025, 60, s42–s51. [Google Scholar] [CrossRef] [Scilit]
- Gharat, M.M.; Roy, P.T.; Gosar, A.N.; Shaikh, T.A.; Wadhava, G.C.; Mirgane, N.A. Development of an Efficient Method to Quantitatively Estimate Dichloroacetic Acid Genotoxic Impurity in Cetirizine Dihydrochloride by Liquid Chromatography-Mass Spectrophotometry. Biomed. Chromatogr. 2025, 39, e70189. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Zhang, D.; Hang, B.; Zhang, Y.; You, P.; Shi, F.; Gong, L. Derivative-Based Non-Target Identification of DNA-Reactive Impurities with Fragment Ion Filtering. Molecules 2025, 30, 3981. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Regulska, K.; Matera-Witkiewicz, A.; Mikołajczyk, A.; Stanisz, B.J. The Degradation Product of Ramipril Is Potentially Carcinogenic, Genotoxic and Mutagenic. Appl. Sci. 2023, 13, 2358. [Google Scholar] [CrossRef] [Scilit]
- Pinter, E.; Rainer, B.; Czerny, T.; Riegel, E.; Schilter, B.; Marin-Kuan, M.; Tacker, M. Evaluation of the Suitability of Mammalian In Vitro Assays to Assess the Genotoxic Potential of Food Contact Materials. Foods 2020, 9, 237. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Reddy, A.V.; Jaafar, J.; Umar, K.; Majid, Z.A.; Aris, A.B.; Talib, J.; Madhavi, G. Identification, control strategies, and analytical approaches for the determination of potential genotoxic impurities in pharmaceuticals: A comprehensive review. J. Sep. Sci. 2015, 38, 764–779. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Kostal, J.; Voutchkova-Kostal, A. Quantum-Mechanical Approach to Predicting the Carcinogenic Potency of N-Nitroso Impurities in Pharmaceuticals. Chem. Res. Toxicol. 2023, 36, 291–304. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Yang, Y.; Gao, J.; Zeng, H. Characterization of 12 Unknown Photodegradation Impurities of Tunlametinib Capsules Using Liquid Chromatography Coupled with ion Trap/Time-Of-Flight Mass Spectrometry. Rapid Commun. Mass Spectrom. 2025, 39, e10113. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Su, Y.; Zhao, B.; Zhang, L.; Shen, B.; Guo, C.; Xiao, H.; Li, N. Quantitative Analysis of Phosphorothioate Isomers in CRISPR sgRNA at Single-Residue Resolution Using Endonuclease Digestion Coupled with Liquid Chromatography Cyclic Ion Mobility Mass Spectrometry (LC/cIMS). Anal. Chem. 2025, 97, 2223–2231. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Aparna, K.; Rachel, K.V.; Rao, K.M.V.N. Advanced analytical techniques for detection, separation and quantification of N-nitroso and related impurities in trimetazidine: A UPLC-PDA, LC-MS/MS, and GC-MS study. Acta Chromatogr. 2026, 38, 25–38. [Google Scholar] [CrossRef] [Scilit]
- Balint, A. Application of Lc-Ms for the Identification and Quantification of Nitrosamine Impurities in Oral Metformin-Based Pharmaceutical Formulations. Farmacia 2025, 73, 924–930. [Google Scholar] [CrossRef] [Scilit]
- Martini, P.R.R.; Machioli, L.F.; Santos, B.P.D.; Oliveira, T.F.; Paula, F.R.; Paim, C.S.; Mendez, A.S.L. Losartan API and Nitrosamines Impurities-Stability Profile Investigation Using HPLC, LC-MS, and In Silico Assessment. J. Sep. Sci. 2026, 49, e70438. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Cech, N.B.; Enke, C.G. Practical implications of some recent studies in electrospray ionization fundamentals. Mass Spectrom. Rev. 2001, 20, 362–387. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Ohno, K.; Yamashita, K. Recent development of chemical derivatization in LC-MS for biomedical approaches. Bioanalysis 2015, 7, 2489–2499. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Panuwet, P.; Hunter, R.E., Jr.; D’Souza, P.E.; Chen, X.; Radford, S.A.; Cohen, J.R.; Marder, M.E.; Kartavenka, K.; Ryan, P.B.; Barr, D.B. Biological Matrix Effects in Quantitative Tandem Mass Spectrometry-Based Analytical Methods: Advancing Biomonitoring. Crit. Rev. Anal. Chem. 2016, 46, 93–105. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Birla, D.; Khandale, N.; Babu, M.R.; Bashir, B.; Alam, M.S.; Vishwas, S.; Chaitanya, M.; Gupta, G.; Chellappan, D.K.; Chawla, R.; et al. An overview of hyphenated techniques used for the identification of genotoxic impurities in pharmaceutical products: Current status and future perspectives. Microchem. J. 2024, 202, 110828. [Google Scholar] [CrossRef] [Scilit]
- Liu, D.Q.; Sun, M.; Kord, A.S. Recent advances in trace analysis of pharmaceutical genotoxic impurities. J. Pharm. Biomed. Anal. 2010, 51, 999–1014. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Bai, L.; Sun, M.; An, J.; Liu, D.Q.; Chen, T.K.; Kord, A.S. Enhancing the detection sensitivity of trace analysis of pharmaceutical genotoxic impurities by chemical derivatization and coordination ion spray-mass spectrometry. J. Chromatogr. A 2010, 1217, 302–306. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Wang, F.; Zuo, L.; Lv, M.; Wang, Y.; Ren, R.; Chen, D.; Sun, Z. Advances in online derivatization for liquid chromatography-mass spectrometry: Automation and performance enhancement. TrAC Trends Anal. Chem. 2025, 191, 118300. [Google Scholar] [CrossRef] [Scilit]
- Muhammad, N.; Hussain, I.; Fu, X.A.; Ali, A.; Guo, D.; Noureen, L.; Subhani, Q.; Ahmad, N.; Zhu, Q.F.; Cui, H.; et al. A Comprehensive Review of Instrumentation and Applications in Post-Column and In-Source Derivatization for LC-MS. Mass Spectrom. Rev. 2026, 45, 879–913. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Raman, N.V.; Prasad, A.V.; Reddy, K.R. Sensitive derivatization methods for the determination of genotoxic impurities in drug substances using hyphenated techniques. J. Pharm. Biomed. Anal. 2014, 89, 276–281. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Wang, J.; Yang, S.; Zhang, K. A simple and sensitive method to analyze genotoxic impurity hydrazine in pharmaceutical materials. J. Pharm. Biomed. Anal. 2016, 126, 141–147. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Thumbar, H.; Dhalani, J.; Patel, H.; Dhaduk, B. In situ identification and quantification of genotoxic sulfonyl chloride impurity in topiramate (Topamax tablets) via LC-MS/MS. MethodsX 2025, 15, 103441. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Bhagwat, S.; Patil, P.; Pawar, R.; Shinde, S.; Amalnerkar, D.; Shinde, D. Development and validation of a method for quantitative determination of the genotoxic impurity diethyl sulfate in pitolisant hydrochloride via high-performance liquid chromatography. RSC Adv. 2025, 15, 16125–16133. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Alsayadi, Y.; Dogra, R.; Arora, V.; Shiven, A. Innovations in the Detection of N-Nitrosamine Impurities in Pharmaceuticals: Analytical and Regulatory Challenges. Crit. Rev. Anal. Chem. 2025, 1–26. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Muller, L.; Mauthe, R.J.; Riley, C.M.; Andino, M.M.; Antonis, D.D.; Beels, C.; DeGeorge, J.; De Knaep, A.G.; Ellison, D.; Fagerland, J.A.; et al. A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity. Regul. Toxicol. Pharmacol. 2006, 44, 198–211. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Hayen, H.; Karst, U. Strategies for the liquid chromatographic-mass spectrometric analysis of non-polar compounds. J. Chromatogr. A 2003, 1000, 549–565. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Shamai Yamin, T.; Madmon, M.; Hindi, A.; Shifrovich, A.; Prihed, H.; Blanca, M.; Weissberg, A. Enhanced LC-ESI-MS/MS Sensitivity by Cationic Derivatization of Organophosphorus Acids. Molecules 2023, 28, 6090. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Tripathi, A.; Suriyamoorthy, P.; Rawson, A. Nitrofuran residues in animal sourced food: Sample extraction and identification methods—A review. Food Chem. Adv. 2023, 3, 100396. [Google Scholar] [CrossRef] [Scilit]
- van Wijk, A.M.; Beerman, B.; Niederländer, H.A.G.; Siebum, A.H.G.; de Jong, G.J. A new approach for generic screening and quantitation of potential genotoxic alkylation compounds by pre-column derivatization and LC-MS/MS analysis. Anal. Bioanal. Chem. 2011, 400, 1375–1385. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Qi, B.-L.; Liu, P.; Wang, Q.-Y.; Cai, W.-J.; Yuan, B.-F.; Feng, Y.-Q. Derivatization for liquid chromatography-mass spectrometry. TrAC Trends Anal. Chem. 2014, 59, 121–132. [Google Scholar] [CrossRef] [Scilit]
- Shivananda, K.B.; Somaprakash, N.; Badiya, P.K. Impurities in Oncology Pharmaceuticals: A Review of Classification, Detection Methods, Regulatory Frameworks and Emerging Trends. Ther. Innov. Regul. Sci. 2026, 60, 756–770. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Kruve, A.; Rebane, R.; Kipper, K.; Oldekop, M.L.; Evard, H.; Herodes, K.; Ravio, P.; Leito, I. Tutorial review on validation of liquid chromatography-mass spectrometry methods: Part I. Anal. Chim. Acta 2015, 870, 29–44. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Szekely, G.; Henriques, B.; Gil, M.; Ramos, A.; Alvarez, C. Design of experiments as a tool for LC-MS/MS method development for the trace analysis of the potentially genotoxic 4-dimethylaminopyridine impurity in glucocorticoids. J. Pharm. Biomed. Anal. 2012, 70, 251–258. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Fan, T.; He, X.; E, H.; Zhang, Y.; Li, X.; Li, X.; Yang, X.; Zhou, C.; Zhao, Z.; Zhao, X. Detection of gyromitrin-induced mushroom poisoning by an isotope-coded derivatization strategy combined with UPLC-MS/MS and its application. Microchem. J. 2024, 199, 110084. [Google Scholar] [CrossRef] [Scilit]
- Zhang, N.; Chen, Q.; Zhang, P.; Zhou, K.; Liu, Y.; Wang, H.; Duan, S.; Xie, Y.; Yu, W.; Kong, Z.; et al. Quartet metabolite reference materials for inter-laboratory proficiency test and data integration of metabolomics profiling. Genome Biol. 2024, 25, 34. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Higashi, T. Derivatization to generate a product ion containing analyte-specific moiety in ESI-MS/MS. Anal. Sci. 2024, 40, 973–974. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Furey, A.; Moriarty, M.; Bane, V.; Kinsella, B.; Lehane, M. Ion suppression; a critical review on causes, evaluation, prevention and applications. Talanta 2013, 115, 104–122. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Antignac, J.-P.; de Wasch, K.; Monteau, F.; De Brabander, H.; Andre, F.; Le Bizec, B. The ion suppression phenomenon in liquid chromatography–mass spectrometry and its consequences in the field of residue analysis. Anal. Chim. Acta 2005, 529, 129–136. [Google Scholar] [CrossRef] [Scilit]
- Lee, H.; Shim, M.; Jung, S.; Han, S.B.; Lee, D.K. Simultaneous determination of genotoxic nitrosamine impurities in sitagliptin/metformin combination tablets: Comparative evaluation of ionisation techniques coupled with LC-MS/MS and high-resolution mass spectrometry. Anal. Methods 2025, 17, 7551–7560. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Kaeslin, J.; Zenobi, R. Resolving isobaric interferences in direct infusion tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2022, 36, e9266. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- van Wijk, A.M.; Niederlander, H.A.; Siebum, A.H.; Vervaart, M.A.; de Jong, G.J. A new derivatization reagent for LC-MS/MS screening of potential genotoxic alkylation compounds. J. Pharm. Biomed. Anal. 2013, 74, 133–140. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Kleijwegt, R.J.T.; Winkenwerder, W.; Baan, W.; van der Schaaf, J. Degradation kinetics and solvent effects of various long-chain quaternary ammonium salts. Int. J. Chem. Kinet. 2021, 54, 16–27. [Google Scholar] [CrossRef] [Scilit]
- Rebane, R.; Oldekop, M.L.; Herodes, K. Matrix influence on derivatization and ionization processes during selenoamino acid liquid chromatography electrospray ionization mass spectrometric analysis. J. Chromatogr. B 2014, 955–956, 34–41. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Vanhoenacker, G.; Dumont, E.; David, F.; Baker, A.; Sandra, P. Determination of arylamines and aminopyridines in pharmaceutical products using in-situ derivatization and liquid chromatography-mass spectrometry. J. Chromatogr. A 2009, 1216, 3563–3570. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Higashi, T.; Ogawa, S. Isotope-coded ESI-enhancing derivatization reagents for differential analysis, quantification and profiling of metabolites in biological samples by LC/MS: A review. J. Pharm. Biomed. Anal. 2016, 130, 181–193. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Gao, S.; Zhang, Z.; Karnes, H. Sensitivity enhancement in liquid chromatography/atmospheric pressure ionization mass spectrometry using derivatization and mobile phase additives. J. Chromatogr. B 2005, 825, 98–110. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- van Wijk, A.M.; Niederlander, H.A.; van Ogten, M.D.; de Jong, G.J. Sensitive CE-MS analysis of potentially genotoxic alkylation compounds using derivatization and electrokinetic injection. Anal. Chim. Acta 2015, 874, 75–83. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- An, J.; Sun, M.; Bai, L.; Chen, T.; Liu, D.Q.; Kord, A. A practical derivatization LC/MS approach for determination of trace level alkyl sulfonates and dialkyl sulfates genotoxic impurities in drug substances. J. Pharm. Biomed. Anal. 2008, 48, 1006–1010. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Wu, X.; Zhu, L.; Visky, D.; Xie, R.; Shao, S.; Liang, X. Derivatization of genotoxic nitroaromatic impurities for trace analysis by LC-MS. Anal. Methods 2014, 6, 7277–7284. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Song, M.; Wu, S.; Lu, P.-B.; Qiao, Y.-N.; Hang, T.-J. A selective and sensitive pre-column derivatization HPLC method for the trace analysis of genotoxic impurity hydroxylamine in active pharmaceutical ingredients. Anal. Methods 2016, 8, 8352–8361. [Google Scholar] [CrossRef] [Scilit]
- Nesetoglu, N.; Unal, D.O. Validated GC-MS and LC-MS/MS Methods for ICH M7-Based Quantification of Alkyl Mesylate and Azido Genotoxic Impurities in Pharmaceutical Products. Biomed. Chromatogr. 2026, 40, e70357. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Nantia, E.A.; Moreno-González, D.; García-Campaña, A.M.; Gámiz-Gracia, L. High-Throughput Methodology for the Determination of Carbamates in Food Supplements by UHPLC–MS/MS. Chromatographia 2016, 80, 63–70. [Google Scholar] [CrossRef] [Scilit]
- Zapata, J.; Temprado, J.; Mateo-Vivaracho, L.; Ferreira, V. Fast and fully automated analytical method for the screening of residues of aziridine and 2-chloroethylamine in pharmaceutical active principles. J. Pharm. Biomed. Anal. 2011, 55, 458–465. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Beranek, J.; Muggli, D.A.; Kubatova, A. Detection limits of electron and electron capture negative ionization-mass spectrometry for aldehydes derivatized with o-(2,3,4,5,6-pentafluorobenzyl)-hydroxylamine hydrochloride. J. Am. Soc. Mass Spectrom. 2010, 21, 592–602. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Wu, L.; Liu, D.Q.; Vogt, F.G.; Kord, A.S. Gas-phase derivatization via the Meerwein reaction for selective and sensitive LC-MS analysis of epoxides in active pharmaceutical ingredients. J. Pharm. Biomed. Anal. 2011, 56, 1106–1111. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Dupard-Julien, C.L.; Kandlakunta, B.; Uppu, R.M. Determination of epoxides by high-performance liquid chromatography following derivatization with N,N-diethyldithiocarbamate. Anal. Bioanal. Chem. 2007, 387, 1027–1032. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Çeğil, T.; Yardımcı, A.; Sevinç, N.; Pamukçu, Z. Determination of dimethyl sulfate genotoxic impurity in pantoprazole sodium sesquihydrate by derivatization method and UPLC/MS. Int. J. Mass Spectrom. 2024, 506, 117330. [Google Scholar] [CrossRef] [Scilit]
- de Carvalho, L.M.; Schwedt, G. Sulfur speciation by capillary zone electrophoresis. J. Chromatogr. A 2005, 1099, 185–190. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Kotecki, B.; Franczyk, T.S.; Allian, A.; Hanna, D.; Diwan, M. Development of a Control Strategy for Hydrogenation of Aryl Nitro Analogs by Kinetic Justification. Org. Process Res. Dev. 2023, 27, 1616–1623. [Google Scholar] [CrossRef] [Scilit]
- An, H.; Ding, Y.; Sautet, P.; Sun, G.; Yan, N. Selective Reduction of Nitroarenes via Noncontact Hydrogenation. J. Am. Chem. Soc. 2024, 146, 29315–29324. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Hottes, E.; Santos, C.; Souza, H.; Lima, M.; Castro, R. Studies Using Hplc-Pda in Gabapentin N-Derivatization Reactions with 9-Fluorenylmethyl Chloroformate (Fmoc-Cl). Quím. Nova 2021, 44, 543–546. [Google Scholar] [CrossRef] [Scilit]
- Shah, S.; Shah, U.; Patel, M.; Patel, S.; Solanki, N. Development and Validation of LC-MS Method for Determination of Genotoxic Impurity N, O-Dimethyl Hydroxylamine by Chemical Derivatization in Investigational Drug Substance. Curr. Pharm. Anal. 2024, 20, 800–807. [Google Scholar] [CrossRef] [Scilit]
- Li, C.; Liu, J.; Liu, P.; Zhou, T.; Yin, G.; Chen, J.; Liu, R. A Universal Strategy for Evaluation and Quantification of Potential Genotoxic Impurities of Hydrazine Derivatives in Isoniazid Injection. J. Sep. Sci. 2025, 48, e70235. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Wang, R.; Zhu, Z.; Qiu, X.; Bai, L.; Guo, W.; Zuo, L.; Zhao, T.; Shan, G. Determination of epoxide impurity in sarpogrelate hydrochloride intermediate by UHPLC and column-switching liquid chromatography. J. Pharm. Biomed. Anal. 2019, 174, 57–62. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Wu, L.; Liu, D.Q.; Kord, A.S. Gas-phase meerwein reaction of epoxides with protonated acetonitrile generated by atmospheric pressure ionizations. J. Am. Soc. Mass Spectrom. 2010, 21, 1802–1813. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Shao, H.; Feng, J.; Zhang, H.; Zhang, Y.; Qin, T.; Hu, Y.; Zhang, W.; Wang, T.; Wu, S.; Yang, Q. Identification and Determination of Impurities in a New Therapeutic Agent for Fatty Liver Disease. J. Anal. Methods Chem. 2023, 2023, 3116223. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Ajabiya, J.; Jawarkar, S.G.; Rajput, A.; Sengupta, P. Perpetual progress in multidimensional chromatographic and mass spectrometric strategies for the resolution of complex matrices: Challenges, innovations, and bioanalytical applications. Microchem. J. 2026, 220, 116741. [Google Scholar] [CrossRef] [Scilit]
- Cuadari, A.; Pollastro, F.; Unciti-Broceta, J.D.; Caprioglio, D.; Minassi, A.; Lopatriello, A.; Munoz, E.; Taglialatela-Scafati, O.; Appendino, G. The dimerization of Delta (9)-tetrahydrocannabinolic acid A (THCA-A). Acta Pharm. Sin. B 2019, 9, 1078–1083. [Google Scholar] [PubMed]
- Tsiasioti, A.; Tzanavaras, P.D. Developments in on-line, post separation sample manipulation in the last 22 years: Pharmaceutical and biomedical applications. J. Pharm. Biomed. Anal. 2023, 235, 115654. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Jones, A.; Pravadali-Cekic, S.; Dennis, G.R.; Shalliker, R.A. Post column derivatisation analyses review. Is post-column derivatisation incompatible with modern HPLC columns? Anal. Chim. Acta 2015, 889, 58–70. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Abdel Rahman, M.H.; Gullick, D.R.; Hoerner, J.; Bartlett, M.G. Determination of genotoxic impurities monomethyl sulfate and dimethyl sulfate in active pharmaceutical ingredients. Anal. Methods 2017, 9, 1112–1118. [Google Scholar] [CrossRef] [Scilit]
- Wu, Y.; Wang, M.; Wang, R.; Yang, S.; Li, W.; Bi, S.; Li, X.; Bai, Y.; Xia, Q.; Lu, H.; et al. Novel Isotope-Coded Photochemical Derivatization Coupled with LC-MS and MS Imaging Platform Enables Sensitive Quantification and Accurate Localization of Amine Submetabolome in Pancreatic Disease. Anal. Chem. 2025, 97, 6611–6619. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Tang, M.; Tan, L.; Zhang, M.; Shi, H.; Zhao, Y.; Xu, D.; Zou, J. Rapid determination of biogenic amines in ossotide injections by microfluidic chip-mass spectrometry platform: Optimization of microfluidic chip derivatization using response surface methodology. Microchem. J. 2024, 199, 109989. [Google Scholar] [CrossRef] [Scilit]
- Isokawa, M.; Nakanishi, K.; Kanamori, T.; Sekiguchi, T.; Funatsu, T.; Shoji, S.; Tsunoda, M. Pillar Array Mixer for Postcolumn Derivatization Integrated into Liquid Chromatography-Based Microfluidic Device. Anal. Chem. 2024, 96, 11002–11008. [Google Scholar] [CrossRef] [Scilit] [PubMed]





| Functional Group | Representative GTI | Derivatization Reagent | Reaction Conditions | Detection | LOD (ppm) | Recovery (%) | RSD (%) | Ref. |
|---|---|---|---|---|---|---|---|---|
| Alkyl halide | Methyl iodide | DMAP | 60 °C, 30 min, acetonitrile | LC-MS/MS | <0.01 | >95 | <5 | [30] |
| Alkyl halide | Ethyl bromide | DMAP | 60 °C, 30 min, ACN | LC-MS/MS | <0.01 | >95 | <5 | [30] |
| Alkyl halide | Methyl chloride | BPPC | 60 °C, 24 h, ACN/NH3 | LC-MS/MS (NLS) | ~1.0 | 40–50 | <10 | [42] |
| Alkyl halide | Benzyl chloride | BPPC | 60 °C, 24 h, ACN/NH3 | LC-MS/MS (NLS) | ~1.0 | 40–50 | <10 | [42] |
| Alkyl halide | Dimethyl sulfate | Triethylamine | RT, 30 min, ACN | UPLC-MS (SIR) | 1.94 × 10−7 | 96.5–106.0 | <5 | [42] |
| Alkyl halide | Alkyl iodides/bromides (general) | DMAP/BPPC | CE-MS with electrokinetic injection | CE-MS | <1.0 | 85–115 | <10 | [48] |
| Alkyl sulfonate | Alkyl sulfonates (general) | BPPC | 60 °C, 24 h, ACN/NH3 | LC-MS/MS (NLS) | ~1.0 | NR | NR | [42] |
| Alkyl sulfonate | Ethyl/propyl/isopropyl sulfonates | Trimethylamine | RT, 30 min, ACN | HILIC-LC/MS | 0.2 | >85 | 0.4–4 | [49] |
| Alkyl sulfonate | Methyl sulfonates | Triethylamine | RT, 30 min, ACN | HILIC-LC/MS | 0.2 | >85 | 0.4–4 | [49] |
| Nitroaromatic | Nitrobenzene | Zn dust/ammonium formate | Room temperature, 30 min, methanol/water | LC-MS/MS | <0.5 | NR | NR | [50] |
| Nitroaromatic | 2-Nitrotoluene | Zn dust/ammonium formate | RT, 30 min, MeOH/H2O | LC-MS/MS | <0.2 | 106–107 | 3.4–5.4 | [50] |
| Nitroaromatic | 3-Nitrotoluene | Zn dust/ammonium formate | RT, 30 min, MeOH/H2O | LC-MS/MS | <0.2 | 103–107 | 3.4–4.5 | [50] |
| Nitroaromatic | 4-Nitrotoluene | Zn dust/ammonium formate | RT, 30 min, MeOH/H2O | LC-MS/MS | <0.2 | 117–119 | 2.8–4.6 | [50] |
| Nitroaromatic | 4-Nitroanisole | Zn dust/ammonium formate | RT, 30 min, MeOH/H2O | LC-MS/MS | <0.2 | 107–108 | 3.3–3.5 | [50] |
| Nitroaromatic | Methyl 2-(bromomethyl)-6-nitrobenzoate | Zn dust/ammonium formate | RT, 30 min, MeOH/H2O | LC-MS/MS | <0.002 | 80–85 | 2.1–3.6 | [50] |
| Sulfonyl chloride | Benzenesulfonyl chloride | Benzylamine | 50 °C, 30 min, anhydrous acetonitrile | LC-MS/MS | NR | 98 (dry solvent)/62 (wet solvent) | NR | [23] |
| Sulfonyl chloride | Topiramate sulfonyl chloride impurity | Benzylamine | 50 °C, 30 min, 1,4-dioxane | LC-MS/MS (MRM) | 0.072 | 96.8–104.4 | <5 | [23] |
| Hydroxylamine | Hydroxylamine (NH2OH) | FMOC-Cl | Room temperature, pH 9.5, aqueous | LC-MS/MS | 0.33 | NR | NR | [51] |
| Hydrazine | Methyl hydrazine carboxylate | Benzaldehyde | RT, 30 min | LC-MS | 1.2 | 83.7–90.3 | 3.5 | [21] |
| Hydrazine | 1,1-Dimethylhydrazine | Salicylaldehyde | RT, 30 min | LC-MS/MS | 0.8 | 90–102 | <6 | [17] |
| Azide | 5-(4′-(azidomethyl)-[1,1′-biphenyl]-2-yl)-1H-tetrazole | Direct analysis (no derivatization) | NR | LC-MS/MS | NR | 93.4–101.7 | 0.85–5.90 | [52] |
| Carbamate | Carbaryl | QuEChERS | NR | UHPLC-MS/MS | 0.0008 | 87.5–102.0 | <10 | [53] |
| Aziridine | Aziridine | PFBCl (2,3,4,5,6-pentafluorobenzoyl chloride) | SPME, 40 °C, 30 min | GC-MS | NR | 95.6–102.4 | 2.6–8.5 | [54] |
| Pyridinium salt | 4-Dimethylaminopyridine | Direct analysis | NR | LC-MS/MS | 0.025 (LOQ) | 94.0–103.0 | 1.9–4.9 | [34] |
| Aromatic amine | 2-Aminopyridine | Hexyl chloroformate (in situ derivatization) | NR | LC-MS | <1 | NR | NR | [45] |
| Aldehyde | Hexanal | PFBHA (pentafluorobenzylhydroxylamine) | RT, 60 min | GC-ECNI-MS | 0.005 | NR | NR | [55] |
| Aldehyde | (S)-tert-Butyl-3-oxo-1-phenylpropylcarbamate (TBC) | 2,4-Dinitrophenylhydrazine | RT, 30 min, HCl | LC-MS | 0.1 | 97.4–101.7 | 3.1 | [21] |
| Carboxylic acid | Valproic acid | 3-Nitrophenylhydrazine | RT, 30 min | LC-MS/MS | 0.006 | 85–108 | <10 | [47] |
| Epoxide | Propylene oxide | APCI source (Meerwein reaction) | Gas-phase (online) | LC-APCI-MS/MS | ≤1.0 | 92–102 | ≤2.2 | [56] |
| Epoxide | Epichlorohydrin | Sodium diethyldithiocarbamate | 60 °C, 20 min | LC-MS/MS | 0.05 | 90–98 | <5 | [57] |
| Acid chloride | Ethyl chloroformate | Aniline | RT, 30 min, pyridine/CCl4 | LC-MS | 10.0 | 99.4–99.9 | 4.8 | [21] |
| Alkyl hydrazine carbamate | Methyl-2-(2-chloro-1-iminomethyl) hydrazine carboxylate | Dimethylamine | RT, 30 min | LC-MS | 1.2 | 84.8–92.8 | 3.1 | [21] |
| Parameter | Zn/NH4COOH | Pd/C + H2 (Catalytic Hydrogenation) | Na2S2O4 (Sodium Dithionite) | Ref. |
|---|---|---|---|---|
| Reaction conditions | Room temperature, 30 min, methanol/water | 1–4 bar H2, 25–60 °C, 2–24 h, methanol or ethyl acetate | 50–70 °C, 30–60 min, aqueous buffer (pH 6–7) | [50,60,61] |
| Typical conversion | High (>90%) | >95% (may vary with catalyst loading) | 79–95% (substrate-dependent) | [50,60] |
| Selectivity for -NO2 | Moderate (may reduce aldehydes, ketones, halogens) | Low (significant risk of dehalogenation when API contains halogens) | Moderate (may reduce azo, imine, quinone groups; less effective for sterically hindered –NO2) | [61] |
| Main advantage | Mild conditions, fast, simple workup | High throughput, catalyst recyclable, green (H2O byproduct) | Mild, inexpensive, compatible with aqueous matrices | [50,60] |
| Main limitation | Zn dust residue; potential API interference | Specialized equipment required (H2 source, pressure reactor); side reactions (dehalogenation) | May generate sulfur-containing byproducts (sulfite, sulfate, thiosulfate) | [50,60,61] |
| Incompatible API functional groups | Halogens, carbonyls (aldehydes, ketones) | Halogens (dehalogenation), C=C, C≡C | Azo, imine, quinone | [61] |
| LC-MS compatibility | Good (reagent residue removable by filtration) | Good (catalyst removal required) | Fair (sulfur compounds may suppress ESI; cleanup recommended) | [50,60] |
| Practical feasibility | High (standard bench equipment) | Medium (requires H2 handling and safety measures) | Medium (requires pH control, byproduct cleanup) | [50,60] |
| Dimension | Pre-Column Derivatization | Post-Column Derivatization | Ref. |
|---|---|---|---|
| Reaction kinetics and conditions | Flexible; 30 min to 24 h at RT-100 °C; compatible with strong nucleophiles, buffers, and non-volatile reagents; slow kinetics (e.g., BPPC with alkyl chlorides, 24 h, 60 °C) is acceptable | Extremely constrained; reaction must complete within seconds to ≤2 min (residence time in reaction coil); only ultra-fast reactions feasible; completely unsuitable for SN2, esterification, amidation, or hydrazone formation | [42,70] |
| Automation and throughput | Offline or automated via programmable autosamplers; 96-well plate parallel processing for fast reactions (≤30 min); batch sizes of 96–384 samples per run | Fully online and theoretically automated; continuous operation; however, reactor maintenance (coil clogging, bubble formation) reduces practical throughput | [19,20,71] |
| Chromatographic resolution | Unaffected; derivatization completed before injection; fully compatible with UHPLC (sub-2 µm columns) and high-resolution separations | Severely degraded; reaction coil adds 50–500 µL dead volume, causing peak broadening and loss of resolution; incompatible with UHPLC; practically limited to conventional HPLC | [19,71] |
| Matrix effects and MS compatibility | Excess reagent and byproducts can be removed by dilution, SPE, or protein precipitation before injection; matrix components do not enter the reaction step | Reagent and byproducts continuously infused into MS; elevated baseline noise (often 3–10× higher); significant ion suppression (typically 20–60% signal loss); severe source fouling | [20,38,44,70] |
| Method robustness and regulatory acceptance | Well-established; fully compatible with ICH Q2(R2) validation; IL-IS corrects yield fluctuations; robustness testing (temperature ±2 °C, time ±5 min) is standard practice | Poor reproducibility due to variable kinetics and continuous background; no IL-IS correction for on-the-fly reaction yield; rarely validated under regulatory guidelines; minimal regulatory acceptance | [33,34] |
| Sample throughput and reagent consumption | Moderate-high; reagent consumption per sample (typically 50–200 µL per reaction); scalable to high-density formats (384-well plates) | Continuous reagent consumption (1–5 mL/min); higher operational cost; reagent stability in pump reservoir becomes a critical issue over long runs | [20] |
| Method development complexity | Moderate; optimization of temperature, time, reagent concentration, and quenching/cleanup steps required; troubleshooting is straightforward | High; requires optimization of coil dimensions, flow rates, reaction temperature, and reagent concentration; complex multi-pump synchronization; difficult to troubleshoot | [19,42,70,71] |
| Suitability for unstable GTIs | Rapid capture possible (e.g., immediate derivatization of sulfonyl chlorides in anhydrous media); no pre-column degradation risk | Unstable GTIs may degrade during LC separation before reaching the reactor; no immediate stabilization | [23,70] |
| Derivatization yield control | Full yield monitoring possible via IL-IS or derivatized control standards; yield can be quantitatively determined by pure standard comparison or difference method | Yield cannot be directly measured or verified batch-to-batch; no independent yield assessment; matrix components may suppress the reaction itself | [21,33,44] |
| Byproduct management | Excess reagent and byproducts can be removed (SPE, dilution, filtration) before injection; reagent blank chromatograms identify interference peaks | Byproducts and excess reagent forced into MS; cannot be removed online; cause constant background and potential false-positive MRM signals | [44] |
| Applicability to specific GTI classes | Universal | Only suitable for inherently fast reactions; limited to gas-phase Meerwein reaction for epoxides; virtually no published application for other GTI classes | [42,51,56,66,72] |
| Practical applicability across GTI classes | Widely adopted in pharmaceutical QC | Very limited; virtually no practical adoption for routine GTI analysis; restricted to specialized applications (epoxides with APCI) | [42,50,51,56,66] |
| Merits | Flexible reaction design; high and consistent conversion achievable; no chromatography compromise; full regulatory acceptance; IL-IS compatible; excess reagent can be removed | Theoretical full automation; minimal manual handling; conceptually elegant; gas-phase variant (APCI) avoids liquid-phase kinetics and band-broadening limitations | [20,66] |
| Limitations | Additional offline sample handling; risk of conversion variability between batches; byproduct interference if not properly controlled | Slow kinetics mismatch for most GTIs; band broadening; continuous background and ion suppression; difficult to validate; poor regulatory acceptance; high method development complexity | [34,44,69,70,71] |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Wang, X.; Chen, Z.; Ji, S. From “Undetectable” to “Sensitive Detection”: Advances in Derivatization Techniques for LC-MS Analysis of Genotoxic Impurities. Molecules 2026, 31, 2889. https://doi.org/10.3390/molecules31162889
Wang X, Chen Z, Ji S. From “Undetectable” to “Sensitive Detection”: Advances in Derivatization Techniques for LC-MS Analysis of Genotoxic Impurities. Molecules. 2026; 31(16):2889. https://doi.org/10.3390/molecules31162889
Chicago/Turabian StyleWang, Xingchen, Zhuzi Chen, and Shunli Ji. 2026. "From “Undetectable” to “Sensitive Detection”: Advances in Derivatization Techniques for LC-MS Analysis of Genotoxic Impurities" Molecules 31, no. 16: 2889. https://doi.org/10.3390/molecules31162889
APA StyleWang, X., Chen, Z., & Ji, S. (2026). From “Undetectable” to “Sensitive Detection”: Advances in Derivatization Techniques for LC-MS Analysis of Genotoxic Impurities. Molecules, 31(16), 2889. https://doi.org/10.3390/molecules31162889
